SamSearch

    Closed Solicitation

    ADVANCED DEVELOPMENT OF MULTIVALENT VACCINE CANDIDATES FOR FILOVIRUS AND LASSA FEVER

    Federal procurement opportunity
    Sol. BAA-NIAID-NIHAI2016064Award Notice
    Closed
    STATUS
    Closed
    —
    POSTED
    Aug 31, 2017
    Publication date
    NAICS CODE
    541715
    Primary industry classification
    PSC CODE
    —
    Product & service classification

    AI Summary

    This opportunity involves the advanced development of multivalent vaccine candidates targeting filovirus and Lassa fever. It is a competitive contract awarded on a cost-plus-fixed-fee basis, focusing on biomedical research and public health initiatives. Bidders should have expertise in vaccine development and infectious disease research.

    Contract details

    Solicitation No.
    BAA-NIAID-NIHAI2016064
    Notice Type
    Award Notice
    Posted Date
    August 31, 2017
    Response Deadline
    —
    NAICS Code
    541715AI guide
    AI Product/Service
    service

    Award information

    Awardee
    Profectus Biosciences, Inc.
    Award Date
    —

    Description

    Contract Type: Cost-Plus-Fixed-Fee, Completion

    Acquisition Method: Competitive - Full and Open

    Key dates

    1. August 31, 2017Posted Date

    AI search tags

    vaccine developmentbiomedical researchpublic healthinfectious disease

    Frequently asked questions

    ADVANCED DEVELOPMENT OF MULTIVALENT VACCINE CANDIDATES FOR FILOVIRUS AND LASSA FEVER is a federal contract award. Review the award details including the awardee, contract value, and NAICS code.

    SamSearch Platform

    Stop searching. Start winning.

    AI-powered intelligence for the right opportunities, the right leads, and the right time.

    Book a Demo